• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,360.01 13.84
( 0.02%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.24 0.16
(0.17%)
EUR-INR
110.83 0.16
(0.15%)
GBP-INR
128.25 0.32
(0.25%)
JPY-INR
0.60 0.00
(0.02%)

EQUITY - MARKET SCREENER

KDDL Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
532054
INE291D01011
312.0827235
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KDDL
47.14
3610.64
EPS(TTM)
Face Value()
Div & Yield %
62.28
10
0
 

midwest gold ltd
Supriya Lifescience's manufacturing unit clears USFDA inspection
Apr 22,2026
Supriya Lifescience announced that the U.S. Food and Drug Administration (US FDA) conducted an inspection at the Company's manufacturing facility located at Lote, Parshuram Industrial Area, Maharashtra, India, from 2 February 2026 to 6 February 2026.

The inspection concluded with the issuance of a Form 483 containing one (1) minor observation. The Company has adequately addressed the observation and has received the Establishment Inspection Report (EIR) indicating “Voluntary Action Indicated (VAI)”, signifying a successful completion of the inspection.